Torri D. Metz, MD

Articles

Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy

The Society for Maternal-Fetal Medicine (SMFM);Richard H. Lee, MD;Mara Greenberg, MD;Torri D. Metz, MD;Christian M. Pettker, MD

June 8th 2021

Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters of pregnancy and is characterized by pruritus and elevated serum bile acid concentrations.

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery

The Society for Maternal-Fetal Medicine (SMFM);Luis D. Pacheco, MD;George Saade, MD;Torri D. Metz, MD

October 5th 2020

The risk of venous thromboembolism is particularly high during the postpartum period and especially following cesarean delivery.

NPMS recommendations: Antepartum vs postpartum prophylaxis

Robert M. Silver, MD;Torri D. Metz, MD

July 19th 2019

Ob/gyns must be aware of the different treatment recommendations for various scenarios pre- and post-delivery.

A simple step to reduce maternal death: Improve VTE prevention

Robert M. Silver, MD;Torri D. Metz, MD

November 16th 2018

As rates of VTE in pregnancy are increasing in the United States, ob/gyns must be vigilant in identifying women at risk and promptly instituting measures recommended by ACOG and other organizations